Catinazzo Thomas 4
4 · Relay Therapeutics, Inc. · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-28$7.29/sh−21,664$157,931→ 313,631 total
Footnotes (2)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 48,115 shares of restricted stock units ("RSUs") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 110,008 shares underlying RSUs.